Protein-protein interaction inhibition (2P2I): fewer and fewer undruggable targets.
Betzi S, Guerlesquin F, Morelli X
Protein-protein interaction inhibition (2P2I): fewer and fewer undruggable targets.
Live
The Marseille Cancer Research Center celebrates its 50th anniversary ! -
The PDZ2 domain of zonula occludens-1 and -2 is a phosphoinositide binding domain.
Meerschaert K, Tun MP, Remue E, De Ganck A, Boucherie C, Vanloo B, Degeest G, Vandekerckhove J, Zimmermann P, Bhardwaj N, Lu H, Cho W, Gettemans J
TET2 gene mutation is a frequent and adverse event in chronic myelomonocytic leukemia.
Kosmider O, Gelsi-Boyer V, Ciudad M, Racoeur C, Jooste V, Vey N, Quesnel B, Fenaux P, Bastie JN, Beyne-Rauzy O, Stamatoulas A, Dreyfus F, Ifrah N, de Botton S, Vainchenker W, Bernard OA, Birnbaum D, Fontenay M, Solary E,
[The future of antibody fragments, made of a single immunoglobulin domain].
Chames P, Baty D
Alternative splicing modulates autoinhibition and SH3 accessibility in the Src kinase Fyn.
Brignatz C, Paronetto MP, Opi S, Cappellari M, Audebert S, Feuillet V, Bismuth G, Roche S, Arold ST, Sette C, Collette Y
p8/nupr1 regulates DNA-repair activity after double-strand gamma irradiation-induced DNA damage.
Gironella M, Malicet C, Cano C, Sandi MJ, Hamidi T, Tauil RM, Baston M, Valaco P, Moreno S, Lopez F, Neira JL, Dagorn JC, Iovanna JL
NMR and MD investigations of human galectin-1/oligosaccharide complexes.
Meynier C, Feracci M, Espeli M, Chaspoul F, Gallice P, Schiff C, Guerlesquin F, Roche P
Distinct beta-clamp interactions govern the activities of the Y family PolIV DNA polymerase.
Wagner J, Etienne H, Fuchs RP, Cordonnier A, Burnouf D
Binding of natural and synthetic polyphenols to human dihydrofolate reductase.
Sánchez-del-Campo L, Sáez-Ayala M, Chazarra S, Cabezas-Herrera J, Rodríguez-López JN
Bispecific antibodies for cancer therapy: the light at the end of the tunnel?
Chames P, Baty D